Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

Stock Information for Envoy Med Inc Cl A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Envoy Med Inc Cl A

908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
908 Devices to Participate in Upcoming Investor Conferences
United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification
908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025
United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices
908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors
908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.